Nolvadex should especially be taken together with the strong androgenic steroids Dianabol (D-Bol) and Anadrol, and the various testosterone compounds. Since most steroids aromatize more or less strongly, i.e. part of the substance is converted into estrogens, male bodybuilders can experience a significant elevation in the normally very low estrogen level. Bodybuilders who take Nolvadex also use anabolic steroids at the same time. The normal application of Nolvadex is in the treatment of certain forms of breast cancer in female patients. "Combining hCG with SERMs like Nolvadex is considered best practice to ensure full HPT axis recovery and reduce the risk of atrophy." — Guay et al., Endocrine Practice "Tamoxifen's rare side effects may include ocular toxicity and thromboembolic events, warranting clinical vigilance." — Jordan, Nature Reviews Cancer These are typically mild and resolve with dose adjustment or discontinuation. As it is not classed as a performance-enhancing drug, the half-life will not likely be of concern regarding drug testing. Females require a very low dosage of Nolvadex for all these effects, with just 10mg per day sufficient. There is no known benefit to taking any more than 40mg of Nolvadex to stimulate testosterone production. 20mg daily of Nolvadex is all we should need to protect against the onset of gyno. The recommended dose of tamoxifen is 20 mg to 40 mg daily taken in 1 dose or in 2 divided doses. Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. You can use it effectively at a lower dose, and it gives me fewer side effects troubles than Clomid. The standard way of using Nolvadex for PCT is to start at a higher dose, which you maintain for between 50% and 75% of the PCT cycle, then halve the dose for the remaining time. That’s why an aromatase inhibitor and HCG are usually combined with Nolvadex during post-cycle therapy to cover all bases. Nolvadex is so powerful in kickstarting your normal testosterone function again so you can avoid the symptoms of low T and enable the maintenance of your gains made on the cycle. It’s not the only useful PCT drug, but it sure is one that you’ll want to keep a steady supply of because Nolvadex has its place in just about any PCT cycle. Athletes who have tendencies toward gynecomastia, strong water retention, and increased fat deposits with steroids such as Dianabol (D-Bol), Testoviron Depot, Anadrol, and Deca Durabolin usually take mg/day. Those who are used to the intake of larger amounts of various steroids do not have to worry about this. If the bodies own estrogen level is unusually high an undesired growth of breast glands occurs. This is especially true for the breast glands in men and women since the body has a large number of estrogen receptors at these glands which can bond with the estrogens present in the blood. The two classes of drugs that you will see bodybuilders and performance athletes who use anabolic steroids (AAS) continually talk about are SERMs and Aromatase Inhibitors (AIs). The other reason we’re interested in SERMs like Nolvadex is their ability to stimulate testosterone production after a suppressive steroid cycle, as they promote the release of the luteinizing hormone and the follicle-stimulating hormone. Nolvadex is valued for PCT purposes thanks to its ability to speed up the recovery of your natural testosterone production after it has been suppressed or shut down by anabolic steroids. Nolvadex effectively takes the place of estrogen in breast tissue – precisely where we need it to be to stop dreaded gyno on cycle. Nolvadex’s development goes right back to the 1960s for medical use, initially for the treatment of breast cancer and later for the prevention of that cancer. This effect, however, is not sufficient to significantly increase the testosterone production reduced by anabolic /androgenic steroids. It belongs to a class of drugs called selective estrogen candy96.fun receptor modulators (SERMs). No, tamoxifen is a type of hormonal therapy. The study found that the benefits of tamoxifen outweighed the risks for 74% of their participants, but not for 20% of their participants. One research study tested the risks vs. benefits of tamoxifen in a group of 788 women. Often, the benefits of taking tamoxifen outweigh the risks.
